Literature DB >> 3948780

Autoregulation of pituitary growth hormone messenger ribonucleic acid levels in rats bearing transplantable mammosomatotrophic pituitary tumors.

S Yamashita, S Slanina, H Kado, S Melmed.   

Abstract

Female Wistar-Furth rats were implanted sc with GH3 rat pituitary tumor cells. Tumors were palpable by 4 weeks, and animals were killed periodically from 5-9 weeks. Tumor-bearing rats (n = 10) were heavier than their respective controls, reaching a weight of 372 +/- 3 by 9 weeks vs. 195 +/- 5 g in controls (mean +/- SE). Circulating serum GH levels increased in tumor-bearing animals from 218 +/- 50 to 9067 +/- 962 ng/ml. Serum insulin-like growth factor I (IGF-I) levels were elevated 3-fold in tumor-bearing rats. After death, pituitary glands were excised, and their total RNA was extracted. GH mRNA was assayed by dot hybridization of immobilized pituitary RNA with [32P]cDNA for rat GH. The hybridization signal was quantified by densitometry of autoradiographs. Pituitary rat GH mRNA levels were suppressed 50% in tumor-bearing animals after 5 weeks. By the end of the 9-week period, pituitary GH mRNA levels were undetectable in tumor-bearing animals. The results show that GH tumor-bearing animals exhibit high levels of circulating GH and IGF-I and suppressed endogenous pituitary GH mRNA levels. This may be caused by autoregulation of pituitary GH gene expression either at the level of the hypothalamus or by a direct effect of GH on the pituitary. Alternatively, the elevated levels of IGF-I may be responsible for the suppression of pituitary GH gene expression .

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3948780     DOI: 10.1210/endo-118-3-915

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

Review 1.  Thyroid hormones and growth hormone secretion.

Authors:  R Valcavi; M Zini; I Portioli
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

2.  GH3 pituitary adenoma cells can reverse thymic aging in rats.

Authors:  K W Kelley; S Brief; H J Westly; J Novakofski; P J Bechtel; J Simon; E B Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Increase in T-type calcium current in atrial myocytes from adult rats with growth hormone-secreting tumors.

Authors:  X P Xu; P M Best
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  Medium flow rate modulates autocrine-paracrine feedback of GH and PRL release by perifused GH3 cells.

Authors:  M E Stachura; C A Lapp; J M Tyler; Y S Lee
Journal:  In Vitro Cell Dev Biol       Date:  1990-05

5.  Skeletal muscle glucose transporter gene expression is not affected by injecting growth-hormone-secreting cells in young rats.

Authors:  H Imamura; I Morimoto; S Etoh; T Usa; H Namba; A Ohtsuru; A Yokota; S Nagataki; S Yamashita
Journal:  Diabetologia       Date:  1993-06       Impact factor: 10.122

6.  Insulinlike growth factor I regulation of growth hormone gene transcription in primary rat pituitary cells.

Authors:  S Yamashita; S Melmed
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

7.  Feed-back effect of growth hormone on hypothalamic opioid and somatocrinin producing neurons.

Authors:  I Ganzetti; F Petraglia; I Capuano; F Rosi; W B Wehrenberg; E E Müller; D Cocchi
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

8.  Constitutive somatostatin receptor subtype 2 activity attenuates GH synthesis.

Authors:  Anat Ben-Shlomo; Oxana Pichurin; Ramtin Khalafi; Cuiqi Zhou; Vera Chesnokova; Song-Guang Ren; Ning-Ai Liu; Shlomo Melmed
Journal:  Endocrinology       Date:  2013-05-21       Impact factor: 4.736

9.  A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axis.

Authors:  Emmanuel Somm; Nicolas Bonnet; Alberto Martinez; Philip M H Marks; Verity A Cadd; Mark Elliott; Audrey Toulotte; Serge L Ferrari; René Rizzoli; Petra S Hüppi; Elaine Harper; Shlomo Melmed; Richard Jones; Michel L Aubert
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

10.  Modulation of pituitary insulin-like growth factor-I bindings in rats bearing somatomammotrophic tumors.

Authors:  K Matsuo; S Yamashita; H Namba; M Niwa; S Harakawa; M Izumi; S Nagataki
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.